Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Atorvastatin (80 mg) in Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Disease

NCT00770796 is registered in ClinicalTrials.gov with Ospedale Misericordia e Dolce as lead sponsor.

NCT NCT00770796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Atorvastatin (80 mg) in Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Disease
Lead sponsor
Ospedale Misericordia e Dolce
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2008
Enrollment
304 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy